Previous reports have found that A204 cells are sensitive to sunitinib and dasatinib (albeit mislabeled as a rhabdomyosarcoma line) through the inhibition of PDGFRα (Bai et al., 2012, McDermott et al., 2009). Here, PDGFRA is linked to rhabdomyosarcoma.